Nath Bio-Genes (India) Limited (BOM:537291)
India · Delayed Price · Currency is INR 153.85
-0.15 (-0.10%)
At close: Aug 21, 2026
Nath Bio-Genes (India) Revenue
Nath Bio-Genes (India) had revenue of 3.28B INR in the quarter ending June 30, 2026, with 15.76% growth. This brings the company's revenue in the last twelve months to 4.90B, up 21.02% year-over-year. In the fiscal year ending March 31, 2026, Nath Bio-Genes (India) had annual revenue of 4.45B with 21.93% growth.
Revenue (ttm)
4.90B
Revenue Growth
+21.02%
P/S Ratio
0.59
Revenue / Employee
10.86M
Employees
451
Market Cap
2.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.45B | 800.62M | 21.93% |
| Mar 31, 2025 | 3.65B | 322.73M | 9.70% |
| Mar 31, 2024 | 3.33B | 314.02M | 10.42% |
| Mar 31, 2023 | 3.01B | 230.01M | 8.26% |
| Mar 31, 2022 | 2.78B | -291.99M | -9.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Amir Chand Jagdish Kumar (Exports) | 25.23B |
| GRM Overseas | 18.69B |
| JK Agri Genetics | 1.50B |
| Mangalam Seeds | 1.25B |
| Indo Us Bio-Tech | 1.13B |
| Tierra Agrotech | 1.12B |
| Sheel Biotech | 1.10B |
| Saptarishi Agro Industries | 937.03M |